Targeted inhibition of signal transducer and activator of transcription 3 (STAT3) may play an anti-cancer role by improving the tumor immune microenvironment and changing the metabolism of cancer cells (Li Y. et al., 2022). This evidence concerns the gene STAT3 and neoplasm.